NCT00372502View on ClinicalTrials.gov

Clinical Trial of the Optimal Endpoint of Early Sepsis Resuscitation

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Severe SepsisSeptic Shock
Interventions
PROCEDURE

Modified EGDT

Early goal directed therapy with lactate clearance

PROCEDURE

Standard EGDT

Early goal directed therapy

Trial Locations (3)

Unknown

Beth Israel Deaconess Medical Center, Boston

Cooper Hospital, Camden

Carolinas Medical Center, Charlotte

All Listed Sponsors
lead

National Institute of General Medical Sciences (NIGMS)

NIH

NCT00372502 - Clinical Trial of the Optimal Endpoint of Early Sepsis Resuscitation | Biotech Hunter | Biotech Hunter